This 14 page paper is a research proposal for health economics to assess the implications of using Invasive Pressure Support Ventilation (NIPSV) rather than Continuous Positive Airway Pressure (CPAP). The paper presents the introduction, a literature review and a proposed methodology. The bibliography cites 20 sources.
Name of Research Paper File: TS65_TEoxyvent.doc
Unformatted Sample Text from the Research Paper:
Study 4 1.3 Constraints and Limitations 4 2. Literature Review 5 2.1 Oxygen Therapy 5 2.2 Non-invasive ventilation and NIPSV 7 2.3 Assessments Models 8 2.3.1 Cost Effectiveness Analysis 9 2.3.2 Cost Benefit Analysis 10 2.3.3 Cost Utility Analysis 10 3. Methodology 11 4. Expected Outcomes 14 1. Introduction The
development of improved methods of treatment, whether ground breaking or minor evolutions on existing approaches, are often associated with a degree of uncertainty due to their newness. In many instances
the newer approaches will not only be treated with a degree of caution due to their newness, there will also be concerns regarding the cost of implementing the newer approaches.
The assessment of the cost may be complex; this is not simply the cost of the treatment to be compared on a like for like comparison with the more conventional
treatments, there are the costs of implementation, and the impact that the newer approaches will have on long term healthcare costs for the patient as well as other costs such
as potential liabilities. One evolutionary change found in oxygen therapy has been the use of non invasive pressure support ventilation (NIPSV) instead of the more traditional oxygen therapy. There
have been a number of studies examining the use of NIPSV in different situations, where it had been found to be either beneficial or having no impact, negative or positive
on most patients outcomes (Agarwal et al, 2009; Masip et al, 2005). The benefits and lack of harm caused by the use of NIPSV may be attractive, and while
studies have taken place which has allowed researchers to assess where and when it is most useful and the conditions in which it may not be the optimal approach, less
attention has been paid to the economics of the treatment. In recent years there has been increasing attention paid to the cost of healthcare; this is especially true where